Abbott Laboratories (ABT) Tax Provisions (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Tax Provisions data on file, last reported at $372.0 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 17.88% year-over-year to $372.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 130.27% YoY), and the FY2025 full-year result was $1.9 billion, up 130.4% from the prior year.
• Tax Provisions fell to $372.0 million in Q1 2026, from $582.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $582.0 million in Q4 2025 to a low of -$7.2 billion in Q4 2024.
• A 5-year average of -$103.6 million and a median of $305.0 million in 2024 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions plunged 3681.59% in 2024 and jumped 114.69% in 2025, its largest moves.
• Tracing ABT's Tax Provisions over 5 years: stood at $287.0 million in 2022, then dropped by 29.97% to $201.0 million in 2023, then sank by 3681.59% to -$7.2 billion in 2024, then jumped by 108.08% to $582.0 million in 2025, then plunged by 36.08% to $372.0 million in 2026.
• Business Quant data shows ABT's Tax Provisions at $372.0 million in Q1 2026, $582.0 million in Q4 2025, and $536.0 million in Q3 2025.